Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 15 Jun 2026 for BeOne Medicines Ltd..
Filing timeline
BuySaleMargaret Dugan
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Margaret Dugan: trading record in brief
Margaret Dugan is a director of BeOne Medicines Ltd. (6 filings) and Chief Medical Officer of Schrodinger, Inc. (4). The 10 filings, published from June 24, 2022 to June 15, 2026, include 7 share grants and 3 sales, but no purchase.
The sales total EUR 106,612, with a median of EUR 25,118. The largest, EUR 56,479, is dated May 22, 2026; next are October 16, 2025 (EUR 25,118) and October 15, 2024 (EUR 25,014). The last two are almost identical and a year apart. Schrodinger has 2 sales, BeOne one.
Filings range from 1 in 2022 to 3 in 2025. Two fall in the last twelve months, including the May 2026 sale. Publication comes a median of 2 days after the trade.
Dugan has 1, 1 and 1 own market trades within 30 days of colleagues at BeOne Medicines Ltd., in that order. All in the same direction. The colleagues, in the same order: Aaron Rosenberg, Baker Bros. Advisors LP and Chan Henry Lee.
Companies and markets linked to Margaret Dugan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
18,980 sharesOrdinary SharesSEC:0001909734-26-000007:0
212 shares@ US$309.60170.0002% mcap100.0% of flowAmerican Depositary SharesSEC:0001909734-26-000006:0
1,395 shares@ US$21.06650.1% of flowCommon StockSEC:0001628280-25-045361:0
10,985 shares0Ordinary SharesSEC:0001651308-25-000087:0
12,500 shares0Common StockSEC:0001490978-25-000019:0
1,531 shares@ US$17.78349.9% of flowCommon StockSEC:0001490978-24-000080:0
16,341 shares0Ordinary SharesSEC:0001651308-24-000065:0
15,000 shares0Common StockSEC:0001490978-23-000099:0
12,922 shares0Ordinary SharesSEC:0001651308-23-000094:0
16,692 shares0Ordinary SharesSEC:0001651308-22-000110:0
10 of 10 declarations
